Free Newsletter
More Seroquel suits dropped on Delaware ruling
Free newsletter via e-mail
Tools
Two more cases have been dismissed in Delaware in the sprawling litigation over AstraZeneca's antipsychotic drug Seroquel, as plaintiffs' attorneys voluntarily dismissed cases that had been set for trial in November. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: